N.sub.1 -Acyl-N.sub.2 -phenyl-diaminopropanols and pharmaceutica

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2604045, 564123, 564170, 564176, 564182, 564188, 564189, 564190, 564207, 564212, 564213, 564220, C07C10338, C07C10378, A61K 31165

Patent

active

044029810

ABSTRACT:
N.sub.1 -acyl-N.sub.2 -phenyl-1,3-diaminopropan-2-ols are disclosed which possess ulcer-inhibiting activities.
Further disclosed are pharmaceutical compositions which are effective in the treatment and prophylaxis of ulcers and which comprise as a pharmacologically active ulcus-inhibiting ingredient N.sub.1 -acyl-N.sub.2 -phenyl-1,3-diaminopropan-2-ols, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable diluent.
Further disclosed are processes for the preparation of the N.sub.1 -acyl-N.sub.2 -phenyl-1,3-diaminopropan-2-ols.

REFERENCES:
patent: 2658076 (1953-11-01), Krimmel
patent: 3906040 (1975-09-01), Vincent et al.
patent: 3998809 (1976-12-01), Milkowski et al.
patent: 4059621 (1977-11-01), Vincent et al.
patent: 4216167 (1980-08-01), Milkowski et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

N.sub.1 -Acyl-N.sub.2 -phenyl-diaminopropanols and pharmaceutica does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N.sub.1 -Acyl-N.sub.2 -phenyl-diaminopropanols and pharmaceutica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sub.1 -Acyl-N.sub.2 -phenyl-diaminopropanols and pharmaceutica will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1592341

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.